MODUXIN MR 35mg prolonged tablets medication leaflet

C01EB15 trimetazidine • Cardiovascular system | Other cardiac preparations

Trimetazidine is a medication primarily used for the treatment of angina pectoris (chest pain caused by reduced blood flow to the heart) and other ischemic heart conditions. It works by optimizing the energy metabolism of myocardial cells (heart cells) under conditions of reduced oxygen supply, thereby protecting the heart from the effects of ischemia.

Trimetazidine is used to reduce the frequency and severity of angina episodes, improving exercise tolerance and the quality of life for patients. It may also be used as an adjunct therapy in other conditions involving tissue ischemia.

Side effects are generally rare but may include dizziness, nausea, headaches, or, in very rare cases, tremors or muscle stiffness. It is important to take the medication as prescribed by a doctor and avoid abrupt discontinuation of treatment.

General data about MODUXIN MR 35mg

Substance: trimetazidine

Date of last drug list: 01-06-2025

Commercial code: W59722004

Concentration: 35mg

Pharmaceutical form: prolonged tablets

Quantity: 30

Product type: generic

Price: 15.47 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: GEDEON RICHTER PLC. - UNGARIA

Holder: GEDEON RICHTER ROMANIA S.A. - ROMANIA

Number: 14012/2021/01

Shelf life: 3 years

Concentrations available for trimetazidine

20mg, 20mg/ml, 35mg, 40mg, 80mg

Compensation lists for MODUXIN MR 35mg GEDEON RICHTER

D - Sublist D with 20% discount from the reference price

Price

Copayment

Patient

15.47 RON

3.09 RON

12.38 RON